메뉴 건너뛰기




Volumn 105, Issue 8, 2010, Pages 1042-1043

Osteoporosis in patients with prostate cancer on long-term androgen deprivation therapy: An increasing, but under-recognized problem

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; DENOSUMAB; GONADORELIN AGONIST; PLACEBO; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TOREMIFENE; VITAMIN D; ZOLEDRONIC ACID;

EID: 77950239175     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09251.x     Document Type: Note
Times cited : (14)

References (12)
  • 1
    • 41649095977 scopus 로고    scopus 로고
    • Clinical practice. Osteoporosis in men
    • Ebeling PR. Clinical practice. Osteoporosis in men. N Engl J Med 2008 358 : 1474 1482
    • (2008) N Engl J Med , vol.358 , pp. 1474-1482
    • Ebeling, P.R.1
  • 2
    • 52449104392 scopus 로고    scopus 로고
    • Osteoporosis in men with prostate cancer: Now for the fracture data
    • Smith MR. Osteoporosis in men with prostate cancer: now for the fracture data. J Clin Oncol 2008 26 : 4371 4372
    • (2008) J Clin Oncol , vol.26 , pp. 4371-4372
    • Smith, M.R.1
  • 3
    • 0030856678 scopus 로고    scopus 로고
    • Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
    • Bolla M, Gonzalez D, Warde P et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. New Engl J Med 1997 337 : 295 300
    • (1997) New Engl J Med , vol.337 , pp. 295-300
    • Bolla, M.1    Gonzalez, D.2    Warde, P.3
  • 4
    • 58649103315 scopus 로고    scopus 로고
    • Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): An open randomised phase III trial
    • Widmark A, Klepp O, Solberg A et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 2009 373 : 301 308
    • (2009) Lancet , vol.373 , pp. 301-308
    • Widmark, A.1    Klepp, O.2    Solberg, A.3
  • 5
    • 27444435258 scopus 로고    scopus 로고
    • A retrospective study of the time to clinical endpoints for advanced prostate cancer
    • Sharifi N, Dahut WL, Steinberg SM et al. A retrospective study of the time to clinical endpoints for advanced prostate cancer. BJU Int 2005 96 : 985 989
    • (2005) BJU Int , vol.96 , pp. 985-989
    • Sharifi, N.1    Dahut, W.L.2    Steinberg, S.M.3
  • 6
    • 1242336807 scopus 로고    scopus 로고
    • Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: Recommendations for diagnosis and therapies
    • Diamond TH, Higano CS, Smith MR, Guise TA, Singer FR. Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies. Cancer 2004 100 : 892 899
    • (2004) Cancer , vol.100 , pp. 892-899
    • Diamond, T.H.1    Higano, C.S.2    Smith, M.R.3    Guise, T.A.4    Singer, F.R.5
  • 7
    • 11844252588 scopus 로고    scopus 로고
    • Risk of fracture after androgen deprivation for prostate cancer
    • Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 2005 352 : 154 164
    • (2005) N Engl J Med , vol.352 , pp. 154-164
    • Shahinian, V.B.1    Kuo, Y.F.2    Freeman, J.L.3    Goodwin, J.S.4
  • 8
    • 0036718472 scopus 로고    scopus 로고
    • Skeletal fractures negatively correlate with overall survival in men with prostate cancer
    • Oefelein MG, Ricchiuti V, Conrad W, Resnick MI. Skeletal fractures negatively correlate with overall survival in men with prostate cancer. J Urol 2002 168 : 1005 1007
    • (2002) J Urol , vol.168 , pp. 1005-1007
    • Oefelein, M.G.1    Ricchiuti, V.2    Conrad, W.3    Resnick, M.I.4
  • 9
    • 34047237418 scopus 로고    scopus 로고
    • Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer
    • Michaelson MD, Kaufman DS, Lee H et al. Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer. J Clin Oncol 2007 25 : 1038 1042
    • (2007) J Clin Oncol , vol.25 , pp. 1038-1042
    • Michaelson, M.D.1    Kaufman, D.S.2    Lee, H.3
  • 10
    • 36749091895 scopus 로고    scopus 로고
    • Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: Interim analysis of a multicenter phase 3 clinical study
    • Smith MR, Malkowicz SB, Chu F et al. Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study. J Urol 2008 179 : 152 155
    • (2008) J Urol , vol.179 , pp. 152-155
    • Smith, M.R.1    Malkowicz, S.B.2    Chu, F.3
  • 11
    • 69049105440 scopus 로고    scopus 로고
    • Denosumab in men receiving androgen-deprivation therapy for prostate cancer
    • Smith MR, Egerdie B, Hernandez Toriz N et al. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med 2009 361 : 745 755
    • (2009) N Engl J Med , vol.361 , pp. 745-755
    • Smith, M.R.1    Egerdie, B.2    Hernandez Toriz, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.